Anik Ghosh

ORCID: 0000-0003-3663-848X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Ovarian cancer diagnosis and treatment
  • Intraperitoneal and Appendiceal Malignancies
  • Endometrial and Cervical Cancer Treatments
  • PARP inhibition in cancer therapy
  • Renal cell carcinoma treatment
  • Cardiac, Anesthesia and Surgical Outcomes
  • COVID-19 and healthcare impacts
  • Appendicitis Diagnosis and Management
  • Testicular diseases and treatments
  • MRI in cancer diagnosis
  • Advances in Oncology and Radiotherapy
  • Uterine Myomas and Treatments
  • Lung Cancer Research Studies
  • Sarcoma Diagnosis and Treatment
  • Gestational Trophoblastic Disease Studies
  • Cervical Cancer and HPV Research
  • Innovations in Medical Education
  • Endometriosis Research and Treatment
  • Glioma Diagnosis and Treatment
  • Brain Metastases and Treatment
  • Cancer, Lipids, and Metabolism
  • Minimally Invasive Surgical Techniques
  • Cancer Mechanisms and Therapy
  • Abdominal Surgery and Complications
  • Ultrasound in Clinical Applications

Tata Medical Center
2016-2024

Institute of Neurosciences Kolkata
2024

Indian Institute of Management Ahmedabad
2022

Gynecologic Oncology Group
2019

Australia New Zealand Gynaecological Oncology Group
2019

Enhanced recovery after surgery (ERAS) protocols have been questioned in patients undergoing cytoreductive (CRS) with/without hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal malignancies. This survey was performed to study clinicians' practice about ERAS CRS-HIPEC.An online survey, comprising 76 questions on elements of prehabilitation (n=11), preoperative (n=8), intraoperative (n=16) and postoperative (n=32) management, conducted. The respondents included surgeons,...

10.1515/pp-2021-0117 article EN cc-by Pleura and Peritoneum 2021-06-18

Background: Choriocarcinoma is the most common form of gestational trophoblastic neoplasia seen by medical oncologists. It a rare condition and data related to its long-term outcomes from Indian subcontinent are sparse. Objectives: The primary objective this study was assess clinicopathological characteristics clinical patients with choriocarcinoma; secondary correlation risk stratification. Materials Methods: This single-center retrospective conducted at Tata Medical Center, tertiary cancer...

10.4103/crst.crst_124_21 article EN cc-by-nc-sa Cancer Research Statistics and Treatment 2021-07-01

Abstract Introduction Locally advanced carcinoma cervix (LACC) is a heterogeneous disease with variable combinations of primary tumour extensions or without nodal involvement. Metabolic information from 18 fluro‐deoxyglucose positron emission tomography combined contrast‐enhanced computerized (FDG PET‐CT) may potentially augment treatment decision‐making for LACC. This study ascertained FDG‐PET CT influence on chemoradiation therapy (CTRT) decisions in We report oncologic and...

10.1111/1754-9485.13667 article EN Journal of Medical Imaging and Radiation Oncology 2024-06-14

Atmospheric lightning is an outcome of interplay among the meteorological parameters under influence convective processes occurring in troposphere. Radiation, temperature and wind are prime driving phenomena. Often, reanalysis data has been utilized to understand precursor occurrences. As a disaster where nowcasting important, for operational utilization, it deemed utilize space-borne near real-time measurements. The present study investigates utilization existing Indian remote sensing...

10.20944/preprints202412.1818.v1 preprint EN 2024-12-20

Postoperative infection rate and clinical outcome after oncosurgery for endometrial carcinoma in a patient population with high prevalence of multidrug-resistant organism colonization multiple comorbidities - Volume 39 Issue 9

10.1017/ice.2018.172 article EN Infection Control and Hospital Epidemiology 2018-08-02

Background: Ovarian germ cell tumours constitute a heterogeneous group of neoplasm with malignant potential being seen in 5% cases.There is limited data on treatment outcomes patients ovarian (MOGCT).Here, we present our hospital audit MOGCT.Material and methods: This retrospective review MOGCT treated between May 2011 December 2019.Patients were staging laparotomy adjuvant chemotherapy, wherever applicable.Surveillance was allowed for those at low risk recurrence.Clinicopathologic features...

10.3332/ecancer.2021.1290 article EN cc-by ecancermedicalscience 2021-09-14

Background: Pre-operative tumor grade influences the type of surgery planned for endometrial cancer, while final affects adjuvant therapy. Aims and Objectives: To predict whether pre tumour can tlymph node dissection therapy in endometriod cancer. Methods: Retrospective observational study. Data was obtained from electronic hospital medical records system. All women with a diagnosis endometrioid cancer who attended TMC, Kolkata between September 2011 June 2015 included. Review histology...

10.1055/s-0039-1685398 article EN cc-by-nc-nd Asian Journal of Oncology 2016-07-01

Background: Debate continues whether primary surgery or neo-adjuvant chemotherapy (NACT) debulking (PDS) should be offered in advanced epithelial ovarian cancer as frontline therapy. Since 2015, there has been a paradigm shift at Tata Medical center, whereas increasing number of patients are being PDS and quality improvement programme was initiated. Recently, ESGO October 2015 published document indicating 10 indicators for cytoreductive surgery. Aim: We compared our performance against all...

10.1055/s-0039-1685291 article EN cc-by-nc-nd Asian Journal of Oncology 2016-07-01

<h3>Introduction/Background</h3> Dual modality treatment in cervical cancer is associated with increased morbidity. This study was conducted to understand the surgical-pathological factors adjuvant treatment, following RH (Radical Hysterectomy), early-stage (ESCC). <h3>Methodology</h3> Single centre retrospective observational a tertiary care India. ESCC patients, who underwent primary surgical between 2011 and 2022, were included. <h3>Results</h3> 64 patients RH. Total 32(50%) needed...

10.1136/ijgc-2023-esgo.168 article EN other-oa 2023-09-01

<h3>Introduction/Background</h3> Breast cancer gene (BRCA) mutation and homologous recombination deficiency (HRD) are useful predictive prognostic biomarkers in epithelial ovarian but their effect on the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) has not been adequately studied. We aimed to assess survival outcomes interval debulking surgery (IDS) with HIPEC advanced (EOC) according BRCA or HRD status. <h3>Methodology</h3> Data all women who underwent IDS between March...

10.1136/ijgc-2023-esgo.669 article EN other-oa 2023-09-01

<h3>Introduction/Background</h3> Small cell carcinoma of the ovary hypercalcemic type (SCCOHT) is a rare malignancy with grave prognosis. Available information on SCCOHT among Indian women limited. This study aimed to describe clinical characteristics, treatment, and outcomes in patients. <h3>Methodology</h3> We conducted retrospective review 8 patients treated at Tata Medical Center between 2012 2021. Relevant data were obtained from electronic medical records. Standard descriptive survival...

10.1136/ijgc-2023-esgo.673 article EN other-oa 2023-09-01

<h3>Introduction/Background</h3> Bevacizumab (Bev) plus neoadjuvant chemotherapy (NACT) with carboplatin and paclitaxel (CP) has shown to improve complete resection rates (CRR) in advanced epithelial ovarian cancer (AEOC) a phase II trial, but its effect on specific metastatic sites is still unknown. We examined region-specific response during interval debulking surgery (IDS) identify subpopulations that benefit most from Bev NACT. <h3>Methodology</h3> retrospectively reviewed 68 patients...

10.1136/ijgc-2023-esgo.691 article EN other-oa 2023-09-01

<h3>Introduction/Background</h3> Inadequate surgical staging in endometrial cancer poses significant challenges delivering optimal care, particularly developing countries. There is a lack of evidence to either recommend or disapprove completion surgeries. We aimed assess the significance restaging surgery treatment this patient population. <h3>Methodology</h3> analysed 84 patients with who underwent at Tata Medical Centre, Kolkata, India, between January 2012 and December 2021. The primary...

10.1136/ijgc-2023-esgo.363 article EN other-oa 2023-09-01

<h3>Introduction/Background</h3> Hyperthermic intraperitoneal chemotherapy (HIPEC) has improved survival in advanced epithelial ovarian cancer (EOC) randomised controlled trials when administered with interval debulking surgery (IDS). There is limited data on IDS HIPEC EOC from India. This study aimed to assess the perioperative and outcomes of Indian women EOC. <h3>Methodology</h3> In this prospective observational study, who underwent for between March 2018 December 2022 at Tata Medical...

10.1136/ijgc-2023-esgo.655 article EN other-oa 2023-09-01

<h3>Introduction/Background</h3> Cytoreductive surgery (CRS), aimed at achieving complete cytoreduction, plays a crucial role in the management of advanced epithelial ovarian cancer (AEOC). However, significant knowledge gap exists regarding optimal extent peritonectomy. Specifically, comparative efficacy and safety total peritonectomy versus selective remain unclear. We to compare clinical outcomes following performed during CRS for AEOC. <h3>Methodology</h3> A retrospective analysis all...

10.1136/ijgc-2023-esgo.643 article EN other-oa 2023-09-01

<h3>Introduction/Background</h3> The presence of suspicious cardiophrenic nodes (CPLN) on computed tomography (CT) upstages epithelial ovarian cancer (EOC) to stage IVB and its surgical resection has not been widely studied. In this study, we aimed surgically evaluate CPLN in patients undergoing cytoreductive surgery (CRS) for advanced EOC who had primary CT. objective is determine histopathological node positivity radiologically CPLN. We also aim the yield, feasibility safety procedure...

10.1136/ijgc-2023-esgo.686 article EN other-oa 2023-09-01
Coming Soon ...